{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:42:08Z","timestamp":1790959328745,"version":"4.1.0"},"reference-count":75,"publisher":"Impact Journals, LLC","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,8,31]]},"DOI":"10.18632\/aging.204207","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T22:56:48Z","timestamp":1659999408000},"page":"6381-6414","source":"Crossref","is-referenced-by-count":47,"title":["Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells"],"prefix":"10.18632","volume":"14","author":[{"given":"David","family":"Rysanek","sequence":"first","affiliation":[{"name":"Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Vasicova","sequence":"additional","affiliation":[{"name":"Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaprakash Narayana","family":"Kolla","sequence":"additional","affiliation":[{"name":"CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sedlak","sequence":"additional","affiliation":[{"name":"CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Andera","sequence":"additional","affiliation":[{"name":"Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Biocev, Institute of Biotechnology of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[{"name":"Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Genome Integrity Unit, Danish Cancer Society Research Center, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Hodny","sequence":"additional","affiliation":[{"name":"Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.08.006","article-title":"Senescence and senotherapeutics: a new field in cancer therapy.","volume":"19","author":"Gorgoulis","year":"2019","journal-title":"Pharmacol Ther"},{"key":"2","doi-asserted-by":"publisher","first-page":"29568","DOI":"10.1074\/jbc.M603307200","article-title":"Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence.","volume":"28","author":"Beaus\u00e9jour","year":"2006","journal-title":"J Biol Chem"},{"key":"3","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.","volume":"6","author":"Campisi","year":"2008","journal-title":"PLoS Biol"},{"key":"4","doi-asserted-by":"publisher","first-page":"e3000599","DOI":"10.1371\/journal.pbio.3000599","article-title":"A proteomic atlas of senescence-associated secretomes for aging biomarker development.","volume":"1","author":"Schilling","year":"2020","journal-title":"PLoS Biol"},{"key":"5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1474-9726.2012.00795.x","article-title":"A senescent cell bystander effect: senescence-induced senescence.","volume":"1","author":"von Zglinicki","year":"2012","journal-title":"Aging Cell"},{"key":"6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","article-title":"Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.","volume":"44","author":"Lowe","year":"2007","journal-title":"Nature"},{"key":"7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","article-title":"An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA.","volume":"3","author":"Campisi","year":"2014","journal-title":"Dev Cell"},{"key":"8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1474-9726.2006.00231.x","article-title":"p16INK4A is a robustbiomarker of cellular aging in human skin.","volume":"5","author":"Wlaschek","year":"2006","journal-title":"Aging Cell"},{"key":"9","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1038\/s41467-019-10335-5","article-title":"Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition.","volume":"1","author":"Antoniou","year":"2019","journal-title":"Nat Commun"},{"key":"10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature16932","article-title":"Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan.","volume":"53","author":"van Deursen","year":"2016","journal-title":"Nature"},{"key":"11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","article-title":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.","volume":"47","author":"van Deursen","year":"2011","journal-title":"Nature"},{"key":"12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cell.2017.02.031","article-title":"Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.","volume":"16","author":"van Cappellen","year":"2017","journal-title":"Cell"},{"key":"13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm.4010","article-title":"Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.","volume":"2","author":"Aykin-Burns","year":"2016","journal-title":"Nat Med"},{"key":"14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse.","volume":"7","author":"Kilmarx","year":"2017","journal-title":"Cancer Discov"},{"key":"15","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.15252\/embj.201695553","article-title":"p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling.","volume":"3","author":"Krizhanovsky","year":"2017","journal-title":"EMBO J"},{"key":"16","first-page":"2284","article-title":"Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved.","volume":"5","author":"Wang","year":"1995","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/onc.2012.206","article-title":"Granule exocytosis mediates immune surveillance of senescent cells.","volume":"3","author":"Krizhanovsky","year":"2013","journal-title":"Oncogene"},{"key":"18","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/s0047-6374(01)00281-0","article-title":"Senescent cells are resistant to death despite low Bcl-2 level.","volume":"12","author":"Mitsui","year":"2001","journal-title":"Mech Ageing Dev"},{"key":"19","doi-asserted-by":"publisher","first-page":"102212","DOI":"10.1016\/j.redox.2021.102212","article-title":"Peroxiredoxin 6 protects irradiated cells from oxidative stress and shapes their senescence-associated cytokine landscape.","volume":"4","author":"Hodny","year":"2022","journal-title":"Redox Biol"},{"key":"20","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1038\/onc.2008.307","article-title":"Bcl-2 family proteins and cancer.","volume":"2","author":"Reed","year":"2008","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","article-title":"The Bcl-2 family: roles in cell survival and oncogenesis.","volume":"2","author":"Adams","year":"2003","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1517\/14728214.2010.515210","article-title":"Emerging Bcl-2 inhibitors for the treatment of cancer.","volume":"1","author":"Sarkar","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"key":"23","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1200\/JCO.2007.15.7693","article-title":"Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents.","volume":"2","author":"N\u00f6r","year":"2008","journal-title":"J Clin Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"11190","DOI":"10.1038\/ncomms11190","article-title":"Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL.","volume":"7","author":"Krizhanovsky","year":"2016","journal-title":"Nat Commun"},{"key":"25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.","volume":"1","author":"Kirkland","year":"2016","journal-title":"Aging Cell"},{"key":"26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours.","volume":"43","author":"Korsmeyer","year":"2005","journal-title":"Nature"},{"key":"27","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.","volume":"6","author":"Xiao","year":"2008","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/bjh.14684","article-title":"Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment.","volume":"17","author":"Dyer","year":"2017","journal-title":"Br J Haematol"},{"key":"29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd.2016.253","article-title":"From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors.","volume":"1","author":"Souers","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bcp.2019.01.015","article-title":"A delicate balance - The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics.","volume":"16","author":"Ge","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"31","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","article-title":"SynergyFinder: a web application for analyzing drug combination dose-response matrix data.","volume":"3","author":"Tang","year":"2017","journal-title":"Bioinformatics"},{"key":"32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1182\/blood-2010-01-262808","article-title":"Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.","volume":"11","author":"Plunkett","year":"2011","journal-title":"Blood"},{"key":"33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1634\/theoncologist.2013-0077","article-title":"U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia.","volume":"1","author":"Kane","year":"2014","journal-title":"Oncologist"},{"key":"34","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1038\/srep08477","article-title":"Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6\/JAK1\/STAT3 signal pathway in Gefitinib-resistant lung cancer cells.","volume":"5","author":"Huang","year":"2015","journal-title":"Sci Rep"},{"key":"35","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1080\/10428190802320368","article-title":"Homoharringtonine inhibits the AKT pathway and inducesandcytotoxicity in human multiple myeloma cells.","volume":"4","author":"Qian","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"36","doi-asserted-by":"publisher","first-page":"100672","DOI":"10.1016\/j.blre.2020.100672","article-title":"Targeting MCL-1 in hematologic malignancies: Rationale and progress.","volume":"4","author":"Stein","year":"2020","journal-title":"Blood Rev"},{"key":"37","doi-asserted-by":"publisher","first-page":"955","DOI":"10.18632\/aging.101202","article-title":"New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463.","volume":"9","author":"Kirkland","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"38","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer.","volume":"7","author":"Campisi","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.201009094","article-title":"Four faces of cellular senescence.","volume":"19","author":"Campisi","year":"2011","journal-title":"J Cell Biol"},{"key":"40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0625.2012.01493.x","article-title":"Cellular senescence: a double-edged sword in the fight against cancer.","volume":"2","author":"Hara","year":"2012","journal-title":"Exp Dermatol"},{"key":"41","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1172\/JCI64098","article-title":"Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.","volume":"12","author":"Kirkland","year":"2013","journal-title":"J Clin Invest"},{"key":"42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1101\/gad.235184.113","article-title":"Cellular senescence and its effector programs.","volume":"2","author":"Narita","year":"2014","journal-title":"Genes Dev"},{"key":"43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10522-013-9473-0","article-title":"Immunosurveillance of senescent cells: the bright side of the senescence program.","volume":"1","author":"Krizhanovsky","year":"2013","journal-title":"Biogerontology"},{"key":"44","doi-asserted-by":"publisher","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age.","volume":"11","author":"Kirkland","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"45","doi-asserted-by":"publisher","first-page":"e12997","DOI":"10.7554\/eLife.12997","article-title":"Targeting senescent cells enhances adipogenesis and metabolic function in old age.","volume":"4","author":"Kirkland","year":"2015","journal-title":"Elife"},{"key":"46","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.18632\/aging.100991","article-title":"Aging of mice is associated with p16(Ink4a)- and \u03b2-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells.","volume":"8","author":"Gudkov","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.","volume":"46","author":"Miller","year":"2009","journal-title":"Nature"},{"key":"48","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/acel.12458","article-title":"Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.","volume":"1","author":"Tchkonia","year":"2016","journal-title":"Aging Cell"},{"key":"49","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1158\/1078-0432.CCR-11-3090","article-title":"Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.","volume":"1","author":"McKeegan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"50","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1182\/blood-2011-04-347849","article-title":"Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets.","volume":"11","author":"Salem","year":"2011","journal-title":"Blood"},{"key":"51","doi-asserted-by":"publisher","first-page":"7145","DOI":"10.1182\/blood-2011-03-344812","article-title":"BCL2\/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation.","volume":"11","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"52","doi-asserted-by":"publisher","first-page":"e1000476","DOI":"10.1371\/journal.pbio.1000476","article-title":"A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation.","volume":"8","author":"Giraudier","year":"2010","journal-title":"PLoS Biol"},{"key":"53","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.18632\/aging.101100","article-title":"Discovery of piperlongumine as a potential novel lead for the development of senolytic agents.","volume":"8","author":"Zheng","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"54","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/gerona\/60.7.820","article-title":"Early-senescing human skin fibroblasts do not demonstrate accelerated telomere shortening.","volume":"6","author":"Rubelj","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1126\/science.7350644","article-title":"Intraclonal variation in proliferative potential of human diploid fibroblasts: stochastic mechanism for cellular aging.","volume":"20","author":"Whitney","year":"1980","journal-title":"Science"},{"key":"56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence.","volume":"42","author":"Jackson","year":"2003","journal-title":"Nature"},{"key":"57","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.18632\/oncotarget.28049","article-title":"Anti-aging: senolytics or gerostatics (unconventional view).","volume":"1","author":"Blagosklonny","year":"2021","journal-title":"Oncotarget"},{"key":"58","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature05268","article-title":"Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.","volume":"44","author":"Tort","year":"2006","journal-title":"Nature"},{"key":"59","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature05327","article-title":"Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.","volume":"44","author":"d\u2019Adda di Fagagna","year":"2006","journal-title":"Nature"},{"key":"60","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi.","volume":"43","author":"Peeper","year":"2005","journal-title":"Nature"},{"key":"61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1289\/ehp.919359","article-title":"Senescence as a mode of tumor suppression.","volume":"9","author":"Sager","year":"1991","journal-title":"Environ Health Perspect"},{"key":"62","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1124\/molpharm.121.000361","article-title":"Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.","volume":"10","author":"Carpenter","year":"2021","journal-title":"Mol Pharmacol"},{"key":"63","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1615\/critrevoncog.2014010630","article-title":"Senescence and the pro-tumorigenic stroma.","volume":"1","author":"Stewart","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"64","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/oxfordjournals.jbchem.a022549","article-title":"5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species.","volume":"12","author":"Ayusawa","year":"1999","journal-title":"J Biochem"},{"key":"65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations.","volume":"1","author":"Pirmohamed","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"66","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jmb.2009.04.005","article-title":"U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome.","volume":"38","author":"Steitz","year":"2009","journal-title":"J Mol Biol"},{"key":"67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-015-0224-3","article-title":"ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.","volume":"8","author":"Liu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"68","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41419-020-02972-2","article-title":"Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemia.","volume":"1","author":"Xu","year":"2020","journal-title":"Cell Death Dis"},{"key":"69","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/cancers13030386","article-title":"Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells.","volume":"1","author":"Wong","year":"2021","journal-title":"Cancers (Basel)"},{"key":"70","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41375-021-01502-z","article-title":"Synergistic activity of combined inhibition of anti-apoptotic molecules in B-cell precursor ALL.","volume":"3","author":"Meyer","year":"2022","journal-title":"Leukemia"},{"key":"71","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.dnarep.2019.04.001","article-title":"PML nuclear bodies are recruited to persistent DNA damage lesions in an RNF168-53BP1 dependent manner and contribute to DNA repair.","volume":"7","author":"Bartek","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"72","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/ijo.2018.4553","article-title":"Distinct phenotypes and \u2018bystander\u2019 effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.","volume":"5","author":"Reini\u0161","year":"2018","journal-title":"Int J Oncol"},{"key":"73","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/onc.2009.318","article-title":"Cytokine expression and signaling in drug-induced cellular senescence.","volume":"2","author":"Hodny","year":"2010","journal-title":"Oncogene"},{"key":"74","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4161\/cc.10.3.14707","article-title":"Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a).","volume":"1","author":"Bartek","year":"2011","journal-title":"Cell Cycle"},{"key":"75","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot087379","article-title":"Crystal Violet Assay for Determining Viability of Cultured Cells.","author":"Leverkus","year":"2016","journal-title":"Cold Spring Harb Protoc"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T14:41:35Z","timestamp":1662388895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":75,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,8,31]]}},"alternative-id":["204207","35951353"],"URL":"https:\/\/doi.org\/10.18632\/aging.204207","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]}}}